Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

导出 LinkOut

翻译打印收藏纠错

作者： Timothy,Carll ^[1] ; Anand,Patel ^[2] ; Benjamin,Derman ^[2] ; Elizabeth,Hyjek ^[1] ; Angela,Lager ^[1] ; Pankhuri,Wanjari ^[1] ; Jeremy,Segal ^[1] ; Olatoyosi,Odenike ^[2] ; Shiraz,Fidai ^[3] ; Daniel,Arber ^[1]

作者单位： Department of Pathology, and. ^[1] Department of Hematology/Oncology, University of Chicago, Chicago, IL; and. ^[2] Department of Pathology and Laboratory Medicine, John H. Stroger Hospital of Cook County, Chicago, IL. ^[3]

主题词人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);表型(Phenotype)

DOI 10.1182/bloodadvances.2019001282

PMID 33049052

发布时间 2021-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood advances

2020年4卷19期

4924-4928页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

Blood advances

相似文献

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

Blood advances

相似文献

Blood advances

相关期刊

检索历史清除